{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:01:42Z","timestamp":1793714502797,"version":"4.6.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.esmoop.2022.100602","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T21:07:47Z","timestamp":1667423267000},"page":"100602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["Salivary gland cancer: ESMO\u2013European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up"],"prefix":"10.1016","volume":"7","author":[{"given":"C.","family":"van Herpen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vander Poorten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Skalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Terhaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Maroldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van Engen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Baujat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.D.","family":"Locati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Smeele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hardillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Costes","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Trama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kinloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Even","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Machiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2022.100602_bib1","author":"Ferlay"},{"key":"10.1016\/j.esmoop.2022.100602_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.oraloncology.2018.03.019","article-title":"Risk factors for salivary gland cancers in France: results from a case-control study, the ICARE study","volume":"80","author":"Radoi","year":"2018","journal-title":"Oral Oncol"},{"issue":"3-4","key":"10.1016\/j.esmoop.2022.100602_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1615\/CritRevOncog.2018027598","article-title":"Current state of knowledge on salivary gland cancers","volume":"23","author":"Lin","year":"2018","journal-title":"Crit Rev Oncog"},{"issue":"13","key":"10.1016\/j.esmoop.2022.100602_bib5","doi-asserted-by":"crossref","first-page":"13067","DOI":"10.1007\/s11356-018-1538-9","article-title":"Air pollution from industrial waste gas emissions is associated with cancer incidences in Shanghai, China","volume":"25","author":"Cong","year":"2018","journal-title":"Environ Sci Pollut Res Int"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100602_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/cncr.30957","article-title":"Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: a case-control study","volume":"124","author":"Sawabe","year":"2018","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100602_bib7","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1158\/1055-9965.EPI-09-0638","article-title":"Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States","volume":"18","author":"Boukheris","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.esmoop.2022.100602_bib8","series-title":"Cancer, Parotid. Treasure","author":"Alvi","year":"2020"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bjoms.2012.10.002","article-title":"Incidence of salivary gland neoplasms in a defined UK population","volume":"51","author":"Bradley","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100602_bib10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","article-title":"Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet \u2013 a population-based study","volume":"18","author":"Gatta","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib11","series-title":"World Health Organization (WHO) Classification of Head and Neck Tumours","author":"El Naggar","year":"2017"},{"key":"10.1016\/j.esmoop.2022.100602_bib12","series-title":"The Milan System for Reporting Salivary Gland Cytopathology","author":"Faquin","year":"2018"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/dc.24097","article-title":"Retrospective assessment of the effectiveness of the Milan system for reporting salivary gland cytology: a systematic review and meta-analysis of published literature","volume":"47","author":"Farahani","year":"2019","journal-title":"Diagn Cytopathol"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100602_bib14","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1245\/s10434-013-2903-z","article-title":"Diagnostic accuracy of fine needle aspiration cytology for high-grade salivary gland tumors","volume":"20","author":"Kim","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib15","first-page":"39","article-title":"Evaluation: fine needle aspiration cytology, ultrasound-guided core biopsy and open biopsy techniques","volume":"78","author":"Howlett","year":"2016","journal-title":"Adv Otorhinolaryngol"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100602_bib16","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/hed.26377","article-title":"Comparison of core needle biopsy and fine-needle aspiration in diagnosis of malignant salivary gland neoplasm: systematic review and meta-analysis","volume":"42","author":"Cho","year":"2020","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100602_bib17","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/lary.26643","article-title":"Fine-needle aspiration with selective use of core needle biopsy of major salivary gland tumors","volume":"127","author":"Romano","year":"2017","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/his.14421","article-title":"Why is the histomorphological diagnosis of tumours of minor salivary glands much more difficult?","volume":"79","author":"Ihrler","year":"2021","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100602_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12105-009-0102-9","article-title":"An update on grading of salivary gland carcinomas","volume":"3","author":"Seethala","year":"2009","journal-title":"Head Neck Pathol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib20","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/PAS.0000000000000980","article-title":"The role of molecular testing in the differential diagnosis of salivary gland carcinomas","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.esmoop.2022.100602_bib21","series-title":"UICC TNM Classification of Malignant Tumours","article-title":"Major salivary glands","author":"O'Sullivan","year":"2017"},{"key":"10.1016\/j.esmoop.2022.100602_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105076","article-title":"The impact of nodal status in major salivary gland carcinoma: a multicenter experience and proposal of a novel N-classification","volume":"112","author":"Lombardi","year":"2021","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5858\/arpa.2018-0422-SA","article-title":"Data set for the reporting of carcinomas of the major salivary glands: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting","volume":"143","author":"Seethala","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.esmoop.2022.100602_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.oraloncology.2016.12.007","article-title":"Surgical treatment of salivary malignant tumors","volume":"65","author":"Lombardi","year":"2017","journal-title":"Oral Oncol"},{"issue":"S2","key":"10.1016\/j.esmoop.2022.100602_bib25","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1017\/S0022215116000566","article-title":"Management of salivary gland tumours: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Sood","year":"2016","journal-title":"J\u00a0Laryngol Otol"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100602_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/hed.23925","article-title":"Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials","volume":"38","author":"Dillon","year":"2016","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100602_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3109\/00016489.2015.1050604","article-title":"Reconstruction of facial nerve after radical parotidectomy","volume":"135","author":"Renkonen","year":"2015","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib28","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1177\/01945998211031161","article-title":"National analysis of oropharyngeal salivary gland malignancies treated with transoral robotic surgery","volume":"166","author":"Bollig","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"19","key":"10.1016\/j.esmoop.2022.100602_bib29","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/cncr.32208","article-title":"Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: incidence and outcomes by site and histological type","volume":"125","author":"Hay","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0194599817735309","article-title":"Minor salivary gland carcinoma of the oropharynx: a population-based analysis of 1426 patients","volume":"158","author":"Goel","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100602_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jso.23100","article-title":"Patterns of lymph node metastasis and their influence on outcomes in patients with submandibular gland carcinoma","volume":"106","author":"Han","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100602_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hed.24981","article-title":"Submandibular gland cancer: specific features and treatment considerations","volume":"40","author":"Aro","year":"2018","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100602_bib33","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2255::AID-CNCR22>3.0.CO;2-D","article-title":"Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors","volume":"85","author":"Vander Poorten","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S0022215116009749","article-title":"Cervical lymph node metastasis in adenoid cystic carcinoma of the major salivary glands","volume":"131","year":"2017","journal-title":"J\u00a0Laryngol Otol"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100602_bib35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jso.23914","article-title":"Patterns and treatment of neck metastases in patients with salivary gland cancers","volume":"111","author":"Yoo","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100602_bib36","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archotol.129.7.720","article-title":"High incidence of lymph node metastasis in major salivary gland cancer","volume":"129","author":"Stennert","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","article-title":"Major and minor salivary gland tumors","volume":"74","author":"Guzzo","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100602_bib38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ejso.2008.02.004","article-title":"Patterns of lymph node spread and its influence on outcome in resectable parotid cancer","volume":"34","author":"Klussmann","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100602_bib39","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1245\/s10434-014-3681-y","article-title":"Treatment of the neck in carcinoma of the parotid gland","volume":"21","author":"Ali","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100602_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO;2-9","article-title":"The indications for elective treatment of the neck in cancer of the major salivary glands","volume":"69","author":"Armstrong","year":"1992","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archotol.1993.01880170041008","article-title":"Predicting occult lymph node metastasis in parotid cancer","volume":"119","author":"Frankenthaler","year":"1993","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100602_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archotol.127.1.56","article-title":"Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas","volume":"127","author":"Regis De Brito Santos","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00405-011-1663-2","article-title":"Occurrence of lymph node metastasis in early-stage parotid gland cancer","volume":"269","author":"Stenner","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib44","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/00016480903062160","article-title":"Indication for elective neck dissection for N0 carcinoma of the parotid gland: a single institution\u2019s 20-year experience","volume":"130","author":"Kawata","year":"2010","journal-title":"Acta Otolaryngol"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100602_bib45","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/hed.23467","article-title":"Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation","volume":"36","author":"Lau","year":"2014","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100602_bib46","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1007\/s00405-015-3855-7","article-title":"Salivary acinic cell carcinoma: reappraisal and update","volume":"273","author":"Vander Poorten","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100602_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijrobp.2004.03.018","article-title":"The role of radiotherapy in the treatment of malignant salivary gland tumors","volume":"61","author":"Terhaard","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100602_bib48","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ijrobp.2006.10.044","article-title":"Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation?","volume":"67","author":"Chen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100602_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.amjoto.2012.11.012","article-title":"Elective neck management for high-grade salivary gland carcinoma","volume":"34","author":"Herman","year":"2013","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100602_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.otohns.2004.09.029","article-title":"Elective neck dissection versus observation in primary parotid carcinoma","volume":"132","author":"Zbaren","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100602_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.joms.2013.05.024","article-title":"Head and neck salivary gland carcinomas--elective neck dissection, yes or no?","volume":"72","author":"Nobis","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib52","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00405-013-2616-8","article-title":"Deep lobe parotidectomy: clinical rationale in the management of primary and metastatic cancer","volume":"271","author":"Olsen","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100602_bib53","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/hed.23249","article-title":"Recent trends in the management of minor salivary gland carcinoma","volume":"36","author":"Vander Poorten","year":"2014","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100602_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12325-016-0298-5","article-title":"Cervical lymph node metastasis in high-grade transformation of head and neck adenoid cystic carcinoma: a collective international review","volume":"33","author":"Hellquist","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.esmoop.2022.100602_bib55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejca.2019.12.026","article-title":"Should a neck dissection be performed on patients with cN0 adenoid cystic carcinoma? A REFCOR propensity score matching study","volume":"130","author":"Atallah","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2022.100602_bib56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.oraloncology.2017.07.025","article-title":"Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: an analysis of the National Cancer Database","volume":"72","author":"Ellis","year":"2017","journal-title":"Oral Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100602_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jso.20993","article-title":"Carcinomas arising in the submandibular gland: high propensity for systemic failure","volume":"97","author":"Roh","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib58","series-title":"Perez & Brady\u2019s Principles and Practice of Radiation Oncology","article-title":"Salivary glands","year":"2018"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100602_bib59","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.clon.2018.08.018","article-title":"Guidelines for clinical target volume definition for perineural spread of major salivary gland cancers","volume":"30","author":"Armstrong","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100602_bib60","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hed.24984","article-title":"Adjuvant therapy in major salivary gland cancers: analysis of 8580 patients in the National Cancer Database","volume":"40","author":"Cheraghlou","year":"2018","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100602_bib61","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/hed.24484","article-title":"Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas","volume":"38","author":"Mifsud","year":"2016","journal-title":"Head Neck"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100602_bib62","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/COC.0000000000000386","article-title":"Concurrent chemoradiotherapy in the adjuvant treatment of high-risk primary salivary gland malignancies","volume":"41","author":"Gebhardt","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100602_bib63","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamaoto.2016.2168","article-title":"Association of adjuvant chemoradiotherapy vs radiotherapy alone with survival in patients with resected major salivary gland carcinoma: data from the National Cancer Data Base","volume":"142","author":"Amini","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.critrevonc.2014.02.002","article-title":"A\u00a0rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network)","volume":"91","author":"Cerda","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.esmoop.2022.100602_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104752","article-title":"Clinical outcomes of head and neck adenoid cystic carcinoma patients treated with pencil beam-scanning proton therapy","volume":"107","author":"Pelak","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2020.01.004","article-title":"Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO","volume":"145","author":"Vischioni","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2019.04.007","article-title":"Feasibility of re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy","volume":"136","author":"Hayashi","year":"2019","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2015.01.002","article-title":"Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy","volume":"114","author":"Jensen","year":"2015","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100602_bib69","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.oraloncology.2015.07.011","article-title":"Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers","volume":"51","author":"Lok","year":"2015","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100602_bib70","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/02841860902740899","article-title":"Hypofractionated radiotherapy denoted as the \u201cChristie scheme\u201d: an effective means of palliating patients with head and neck cancers not suitable for curative treatment","volume":"48","author":"Al-mamgani","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib71","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.oraloncology.2016.10.018","article-title":"Lung metastasectomy in adenoid cystic cancer: is it worth it?","volume":"65","author":"Girelli","year":"2017","journal-title":"Oral Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100602_bib72","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.oraloncology.2005.04.014","article-title":"Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland","volume":"41","author":"Locati","year":"2005","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib73","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ejcts.2007.12.057","article-title":"Lung metastasis resection of adenoid cystic carcinoma of salivary glands","volume":"33","author":"Bobbio","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100602_bib74","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0300891620952844","article-title":"Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series","volume":"107","author":"Bergamini","year":"2021","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib75","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/odi.13755","article-title":"Metastatic salivary gland carcinoma: a role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group","volume":"28","author":"Franzese","year":"2022","journal-title":"Oral Dis"},{"issue":"13","key":"10.1016\/j.esmoop.2022.100602_bib76","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1245\/s10434-016-5356-3","article-title":"Risk factors and survival associated with distant metastasis in patients with carcinoma of the salivary gland","volume":"23","author":"Nam","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101906","article-title":"Advances and challenges in precision medicine in salivary gland cancer","volume":"80","author":"Lassche","year":"2019","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100602_bib78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hed.10400","article-title":"Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch Head and Neck Oncology Cooperative Group","volume":"26","author":"Terhaard","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.esmoop.2022.100602_bib79","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oraloncology.2016.12.016","article-title":"Systemic therapy in metastatic salivary gland carcinomas: a pathology-driven paradigm?","volume":"66","author":"Alfieri","year":"2017","journal-title":"Oral Oncol"},{"issue":"29","key":"10.1016\/j.esmoop.2022.100602_bib80","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1038\/onc.2013.348","article-title":"Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100602_bib81","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70245-X","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review","volume":"12","author":"Laurie","year":"2011","journal-title":"Lancet Oncol"},{"issue":"suppl 4","key":"10.1016\/j.esmoop.2022.100602_bib82","doi-asserted-by":"crossref","first-page":"S663","DOI":"10.1016\/j.annonc.2020.08.1034","article-title":"919MO ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent\/metastatic (R\/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut)","volume":"31","author":"Ferrarotto","year":"2020","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.esmoop.2022.100602_bib83","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1158\/1078-0432.CCR-21-1061","article-title":"Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100602_bib84","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00405-018-4985-5","article-title":"Polymorphous adenocarcinoma of the salivary glands: reappraisal and update","volume":"275","author":"Vander Poorten","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100602_bib85","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.oraloncology.2009.05.635","article-title":"Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)","volume":"45","author":"Locati","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102069","article-title":"Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: a systematic review","volume":"89","author":"Uijen","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100602_bib87","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hed.25035","article-title":"Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: a nationwide case series of 35 patients in The Netherlands","volume":"40","author":"Boon","year":"2018","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100602_bib88","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/annonc\/mdx771","article-title":"A\u00a0prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma","volume":"29","author":"Fushimi","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2022.100602_bib89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2018.12.035","article-title":"Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma","volume":"110","author":"van Boxtel","year":"2019","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib90","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.18.00545","article-title":"Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma","volume":"37","author":"Takahashi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 15","key":"10.1016\/j.esmoop.2022.100602_bib91","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1200\/JCO.2019.37.15_suppl.6001","article-title":"Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): results from a phase II basket trial","volume":"37","author":"Li","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.esmoop.2022.100602_bib92","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","article-title":"Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer","volume":"22","author":"Dalin","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100602_bib93","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.6004\/jnccn.2018.7056","article-title":"First-line treatment of widely metastatic BRAF-mutated salivary duct carcinoma with combined BRAF and MEK inhibition","volume":"16","author":"Lin","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib94","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/his.13944","article-title":"The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma","volume":"75","author":"Xu","year":"2019","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100602_bib95","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100602_bib96","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100602_bib97","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/annonc\/mdw042","article-title":"What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)","volume":"27","author":"Drilon","year":"2016","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100602_bib98","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent-front mutations","volume":"8","author":"Drilon","year":"2018","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100602_bib99","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cpet.2021.12.002","article-title":"18)F-fluorodeoxyglucose PET\/computed tomography: head and neck salivary gland tumors","volume":"17","author":"Broski","year":"2022","journal-title":"PET Clin"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100602_bib101","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A\u00a0framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100602_bib102","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/annonc\/mdx310","article-title":"ESMO-Magnitude of Clinical Benefit Scale version 1.1","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100602_bib103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"33","author":"Dykewicz","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100602_bib104","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinids\/18.3.421","article-title":"Purpose of quality standards for infectious diseases. Infectious Diseases Society of America","volume":"18","author":"Gross","year":"1994","journal-title":"Clin Infect Dis"}],"updated-by":[{"DOI":"10.1016\/j.esmoop.2023.101630","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000}}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922002320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922002320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T03:45:46Z","timestamp":1728272746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702922002320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2059702922002320"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100602","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary gland cancer: ESMO\u2013European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100602"}}